Centessa Pharmaceuticals Plc ADR (CNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 62,431 | 61,299 | 50,811 | 44,242 | 105,156 |
| Marketable Securities | 214,158 | 233,281 | 195,403 | 206,482 | 179,349 |
| Receivables | 56,431 | 53,917 | 49,121 | 40,704 | 49,608 |
| TOTAL | $348,679 | $367,875 | $307,675 | $300,363 | $347,718 |
| Non-Current Assets | |||||
| PPE Net | 722 | 807 | 894 | 733 | 681 |
| Investments And Advances | 257,117 | 282,548 | 102,825 | 153,406 | 140,395 |
| Other Non-Current Assets | 35,245 | 36,265 | 36,906 | 37,625 | 39,051 |
| TOTAL | $293,084 | $319,620 | $140,625 | $191,764 | $180,127 |
| Total Assets | $641,763 | $687,495 | $448,300 | $492,127 | $527,845 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,658 | 7,582 | 8,683 | 5,692 | 5,132 |
| Accrued Expenses | 25,916 | 35,353 | 20,439 | 24,002 | 19,070 |
| TOTAL | $36,574 | $42,935 | $29,122 | $29,694 | $24,202 |
| Non-Current Liabilities | |||||
| Long Term Debt | 110,440 | 110,095 | 109,816 | 109,545 | 109,252 |
| Other Non-Current Liabilities | 7,401 | 7,602 | 7,788 | 7,969 | 8,144 |
| TOTAL | $117,841 | $117,697 | $117,604 | $117,514 | $117,396 |
| Total Liabilities | $154,415 | $160,632 | $146,726 | $147,208 | $141,598 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 154,569 | 134,448 | 134,073 | 133,619 |
| Common Shares | 419 | 405 | 364 | 363 | 362 |
| Retained earnings | -1,265,475 | -1,186,234 | -1,120,071 | -1,065,180 | -1,014,837 |
| Other shareholders' equity | 1,408 | 2,714 | 2,600 | 1,591 | 2,075 |
| TOTAL | $487,348 | $526,863 | $301,574 | $344,919 | $386,247 |
| Total Liabilities And Equity | $641,763 | $687,495 | $448,300 | $492,127 | $527,845 |